Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference31 articles.
1. Mortality is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics;Albertsson-Wikland;J. Clin. Endocrinol. Metab.,2016
2. Changes in the risk of reaching multiple sclerosis disability milestones in recent decades: a nationwide population-based cohort study in Sweden;Beiki;JAMA Neurol.,2019
3. Immunomodulatory therapies delay disease progression in multiple sclerosis;Bergamaschi;Mult. Scler.,2016
4. Statistical methods in cancer research. Volume II–The design and analysis of cohort studies;Breslow;IARC Sci. Publ.,1987
5. Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis;Brown;JAMA,2019
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Using instrumental variables to correct for bias in real-world cohort studies of the effects of disease-modifying treatment in MS;Multiple Sclerosis Journal;2023-10-03
2. Carboplatin ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by inducing T cell apoptosis;International Immunopharmacology;2023-08
3. Molecular biomarkers and cognitive impairment in multiple sclerosis: State of the field, limitations, and future direction – A systematic review and meta-analysis;Neuroscience & Biobehavioral Reviews;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3